Published in Ann N Y Acad Sci on October 01, 2009
Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia. Int J Alzheimers Dis (2011) 1.15
Practical management of heterogeneous neuroimaging metadata by global neuroimaging data repositories. Front Neuroinform (2012) 0.91
The emerging agenda of stratified medicine in neurology. Nat Rev Neurol (2013) 0.85
Do Microglia Default on Network Maintenance in Alzheimer's Disease? J Alzheimers Dis (2016) 0.75
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol (2010) 5.03
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol (2006) 4.19
Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A (2002) 4.07
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol (2009) 3.82
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol (2010) 3.47
A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol (2003) 3.44
Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol (2003) 3.26
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol (2007) 3.22
Fast free-form deformation using graphics processing units. Comput Methods Programs Biomed (2009) 3.18
Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage (2002) 3.06
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol (2012) 2.75
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain (2012) 2.65
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther (2011) 2.51
Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry (2010) 2.44
Posterior cortical atrophy. Lancet Neurol (2012) 2.41
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage (2010) 2.32
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele. Lancet Neurol (2010) 2.18
Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42. Ann Neurol (2010) 2.15
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain (2008) 2.13
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain (2011) 2.13
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet (2013) 2.09
Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol (2003) 2.07
Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol (2005) 2.06
Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain (2013) 2.05
Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet (2003) 2.02
Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage (2008) 2.00
Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage (2010) 1.99
Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage (2007) 1.93
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain (2011) 1.89
STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation. Med Image Anal (2013) 1.85
Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study. Ann Neurol (2006) 1.81
Shining a light on posterior cortical atrophy. Alzheimers Dement (2012) 1.77
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord (2012) 1.75
The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology (2013) 1.74
Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. Neuroimage (2009) 1.71
The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort. Arch Neurol (2004) 1.67
Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain (2008) 1.64
Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage (2010) 1.62
A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging (2008) 1.61
Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression. J Neurol (2008) 1.60
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement (2011) 1.59
Neurofilament inclusion body disease: a new proteinopathy? Brain (2003) 1.59
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Ten simple rules for reporting voxel-based morphometry studies. Neuroimage (2008) 1.57
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology (2008) 1.56
Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage (2009) 1.53
Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates. Neuroimage (2004) 1.48
Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain (2006) 1.47
The clinical profile of right temporal lobe atrophy. Brain (2009) 1.46
Peregrine and saker falcon genome sequences provide insights into evolution of a predatory lifestyle. Nat Genet (2013) 1.45
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron (2013) 1.45
Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. Eur Radiol (2009) 1.43
Suspected early dementia. BMJ (2011) 1.41
VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage (2007) 1.40
The diagnosis of young-onset dementia. Lancet Neurol (2010) 1.37
Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.37
Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage (2007) 1.37
Brain MAPS: an automated, accurate and robust brain extraction technique using a template library. Neuroimage (2010) 1.37
Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol (2006) 1.35
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Curr Alzheimer Res (2009) 1.34
Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease. Neurobiol Aging (2009) 1.33
Apolipoprotein e genotype modifies the phenotype of Alzheimer disease. Arch Neurol (2006) 1.30
Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends Neurosci (2013) 1.29
A comparison of voxel and surface based cortical thickness estimation methods. Neuroimage (2011) 1.29
Consistent multi-time-point brain atrophy estimation from the boundary shift integral. Neuroimage (2011) 1.28
Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain (2007) 1.27
Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement (2012) 1.27
Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol (2010) 1.26
Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease. J Alzheimers Dis (2010) 1.23
Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol (2005) 1.22
Longitudinal patterns of regional change on volumetric MRI in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord (2004) 1.22
Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cereb Cortex (2006) 1.21
Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol (2008) 1.20
LoAd: a locally adaptive cortical segmentation algorithm. Neuroimage (2011) 1.17
Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain (2010) 1.17
Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nat Clin Pract Neurol (2008) 1.17
Genetic variability in CLU and its association with Alzheimer's disease. PLoS One (2010) 1.16
Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology (2013) 1.16
Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia (2008) 1.15
Delusions in frontotemporal lobar degeneration. J Neurol (2009) 1.14
Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Mov Disord (2009) 1.14
Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease. Eur Radiol (2009) 1.14
Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging (2006) 1.14
Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiol Aging (2006) 1.12
Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology (2012) 1.10
Basic visual function and cortical thickness patterns in posterior cortical atrophy. Cereb Cortex (2011) 1.10